Respiratory

The sponsor of the below article (GSK) have requested its retraction in accordance with their internal compliance requirements following…

This ERS International Congress 2023 review considers prioritising patient outcomes to ensure access to essential inhaled medicines when considering the carbon footprint of inhalers.

The main objective was to discuss unmet needs in the diagnosis and management of rare lung diseases, with a particular emphasis on alpha…

Approximately 262 million people have asthma globally, with around 1,000 asthma-related deaths every day. In Europe alone…

Rabe began the presentation by highlighting two hypothetical patients with different ages, physiologies, and backgrounds to contextualise…

Nebuliser therapy is a relevant therapy option for respiratory diseases, yet studies have demonstrated a wide variation in nebuliser drug…

Chronic obstructive pulmonary disease (COPD) is a leading cause of death. This review focuses on the development of biofilms, and…

The manuscript describes the physiotherapeutic techniques used and collects the main scientific evidence on them. The main purpose…